Consent statement for SaxendaCare® pharmacy enrolment


Consent:


Novo Nordisk Pharmaceuticals Pty Ltd (Novo Nordisk) owns and operates the SaxendaCare® Patient Support Program (SaxendaCare®). By enrolling a pharmacy in SaxendaCare® Novo Nordisk will collect personal information about you. This personal information will be used for the purpose of pharmacy registration and to provide updates in relation to SaxendaCare® . Your personal information may be shared, where required, with third parties providing support to SaxendaCare®.  

Personal information will be handled in accordance with Novo Nordisk’s Privacy Policy (Privacy Policy), found here. The Privacy Policy contains details as to how an individual may request access to their personal information, and how to make a privacy related complaint. An individual can withdraw their consent relating to the handling of their personal information by contacting Novo Nordisk’s Privacy Officer at privacyofficeroceania@novonordisk.com.


                                                                                                                                                                                       Date of preparation Nov 2023, AU23SX00140